7 results on '"Europe/epidemiology"'
Search Results
2. Comprendre les immunodéficiences primaires avec un registre
- Author
-
Jandus, Peter, Grange, Elliot, and Seebach, Jorg Dieter
- Subjects
ddc:616 ,Biomedical Research ,education ,Humans ,Immunoglobulins, Intravenous/therapeutic use ,Registries ,Immunologic Deficiency Syndromes/classification/epidemiology/therapy ,Europe/epidemiology - Abstract
Primary Immunodeficiency Diseases (PID) comprise inborn defects of the immune system which are and therefore difficult to study For this reason, the European Society for ImmunoDeficiencies (ESID) has set up an internet-based international patient and research database which integrates research data with more detailed clinical information. These disorders are not only found in children, but also in adults resulting in a wide range of clinical manifestations. Primary immunodeficiency adults are much less known and may remain undiagnosed.
- Published
- 2016
3. Mesure de l'état de santé de la population
- Author
-
Flahault, Antoine, Azouvi, Philippe, Jourdan, Claire, and Schnitzler, Alexis
- Subjects
Adult ,Congenital Abnormalities/epidemiology/prevention & control ,Life Expectancy/trends ,Longevity ,Health Status ,Global Health ,World Health Organization ,France/epidemiology ,Europe/epidemiology ,Disabled Persons/statistics & numerical data ,Prevalence ,Health Status Indicators ,Humans ,Public Health/statistics & numerical data ,Child ,Mortality/trends - Published
- 2014
4. Douleurs chroniques et dépression: un aller-retour?
- Author
-
Allaz, Anne-Françoise and Piguet, Valérie
- Subjects
Evidence-Based Medicine ,Switzerland/epidemiology ,Chronic Pain/diagnosis/epidemiology/therapy ,ddc:618.97 ,Humans ,Pain Measurement/methods ,Europe/epidemiology - Published
- 2013
5. Pancréatite autoimmune
- Author
-
Vonlaufen, Alain and Frossard, Jean-Louis
- Subjects
ddc:616 ,Diagnosis, Differential ,Glucocorticoids/therapeutic use ,Pancreatitis, Chronic/*diagnosis/drug therapy/epidemiology/*immunology ,Treatment Outcome ,Autoimmune Diseases/*diagnosis/drug therapy/epidemiology ,Jaundice, Obstructive/diagnosis/immunology ,Exocrine Pancreatic Insufficiency/diagnosis/immunology ,Humans ,ddc:616.0757 ,Europe/epidemiology - Abstract
Autoimmune pancreatitis (ALP) represents a distinct form of chronic pancreatitis initially described in Japan but now reported worldwide. AIP often presents with obstructive jaundice/pancreatic mass as well as pancreatic exocrine and endocrine insufficiency. Histologically, it is characterised by a lymphoplasmacytic infiltrate with fibrosis. The disease responds readily to steroids in 70-80% of cases. Given the absence of unified diagnostic criteria, the diagnosis of AIP proves difficult. In particular, distinguishing ALP from pancreatic or biliary cancer remains a challenging task. In order to avoid unnecessary resections for an otherwise benign and easily treatable condition, it is urgent to refine diagnostic criteria and to reach an international consensus.
- Published
- 2010
6. [Epidemiology of viral gastroenteritis in France and Europe]
- Author
-
Thomas Hanslik, Antoine Flahault, Turbelin, Clément, Epidémiologie des maladies infectieuses et modélisation (ESIM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), and École des Hautes Études en Santé Publique [EHESP] (EHESP)
- Subjects
Diarrhea ,Diarrhée ,Epidemiology ,Rotavirus Infections ,Reoviridae ,MESH: Health Care Costs ,Virus Diseases/economics/*epidemiology/prevention & control/virology ,France/epidemiology ,MESH: Rotavirus Vaccines ,Europe/epidemiology ,Infections à rotavirus ,03 medical and health sciences ,0302 clinical medicine ,Political science ,Human rotavirus ,Humans ,Rotavirus Vaccines/economics/therapeutic use ,030212 general & internal medicine ,Rotavirus Infections/epidemiology/prevention & control ,0303 health sciences ,MESH: Humans ,biology ,030306 microbiology ,General Medicine ,Health Care Costs ,MESH: Rotavirus ,Epidémiologie ,MESH: Rotavirus Infections ,biology.organism_classification ,MESH: Gastroenteritis ,3. Good health ,Gastroenteritis ,Gastroentérite ,Gastroenteritis/economics/*epidemiology/prevention & control/virology ,MESH: France ,Rotavirus infections ,MESH: Virus Diseases ,Rotavirus/immunology ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,MESH: Sentinel Surveillance ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,MESH: Europe ,Humanities ,Sentinel Surveillance - Abstract
Continuous surveillance of acute diarrhea in France has been conducted by Inserm's sentinel network of general practitioners (GP) since 1991. Similar GP-based studies have been performed in the Netherlands, Austria and the UK. The causes of most cases of acute diarrhea are unclear. In case-controlstudies designed to identify viruses in stools, 35 to 40% of cases and virtually none of the controls were positive for one of 4 major viruses (rotavirus, calicivirus, astrovirus and adenovirus). Thus, no viral cause was identified in more than 60% of patients with acute diarrhea. The causative role of viruses such as torovirus, picobirnavirus, picornavirus and enterovirus 22 has rarely been investigated. Further investigations are needed to identify other viral, bacterial fungal or parasitic causes of acute diarrhea. In France, on average, more than 3 million people (predominantly children) visit a GP for acute diarrhea each year. Most of these patients recover spontaneously within a few days, but the medical, social and economic costs of acute diarrhea are sufficiently high to justify a more aggressive public policy to prevent and control epidemics in Europe., COMMUNICATION SCIENTIFIQUESéance du 9 novembre 2010Malgré une surveillance permanente et continue des diarrhées aiguës sur le territoire français assurée par les médecins généralistes du réseau Sentinelles de l’Inserm depuis 1991, et la mise en place de systèmes de surveillance similaires ou des études en médecine générale dans d’autres pays d’Europe, notamment aux Pays-Bas, en Autriche et au Royaume-Uni, force est de constater que leur étiologie reste encore largement méconnue. Si des études cas-témoins conduites avec une recherche de virus dans les selles ont permis d’identifier un virus dans 35 à 40 % des cas et chez un faible nombre de témoins, en faveur d’un rôle causal probable de quatre virus principalement retrouvés lors des épidémies (rotavirus, calicivirus, astrovirus et adénovirus), dans plus de 60 % des cas la cause de ces diarrhées aigües hivernales ou estivales reste inconnue. Le rôle de virus actuellement peu ou pas recherchés comme les torovirus, picobirnavirus, picornavirus ou entérovirus 22 mériterait d’être précisé. Des recherches restent donc à conduire, notamment visant à l’identification plus étendue d’agents pathogènes potentiellement responsables, qu’ils soient viraux, bactériens, fongiques ou parasitaires, avant de pouvoir espérer prévenir et contrôler de manière efficace ces épidémies récurrentes en Europe, qui concernent de larges segments de la population. En France environ trois millions de personnes consultent en moyenne chaque année leur médecin généraliste pour un épisode de diarrhée aiguë (ce sont des patients de tous âges, bien que plus souvent des enfants). Si pour l’immense majorité des cas leur évolution favorable est spontanée en quelques jours, le coût sanitaire, social et économique de ces épidémies d’ampleur nationale est très élevé et justifierait une politique de prévention et de lutte plus ambitieuse à l’échelle de l’Europe,.
- Published
- 2010
7. Enjeux, stratégies de traitement et évolution clinique des bactériémies a SARM
- Author
-
Pittet, Didier
- Subjects
Male ,Staphylococcus aureus ,Bacteremia/epidemiology/etiology/ therapy ,Cross Infection/epidemiology/etiology/ therapy ,Staphylococcal Infections/epidemiology/etiology/ therapy ,Intensive Care/ methods ,bacterial infections and mycoses ,Prognosis ,United States/epidemiology ,Pressure Ulcer/complications ,Europe/epidemiology ,Japan/epidemiology ,Length of Stay/statistics & numerical data ,Risk Factors ,Drug Resistance, Bacterial ,Disease Progression ,Humans ,ddc:576.5 ,Catheters, Indwelling/adverse effects ,Female ,Methicillin Resistance ,Hospital Mortality ,Safety ,Infection Control/ methods ,Disinfection/methods - Abstract
DISTURBING EPIDEMIOLOGICAL DATA: Over the past decade there has been a continuous progression in the percentage of Staphylococcus aureus strains resistant to methicillin (MRSA), a slight progression in coagulase-negative staphylococci strains resistant to methicillin and a spectacular progression of enterococci resistant to glycopeptides, not only in hospitals but also in intensive care settings. The increase in nosocomial septicemia is currently a major patient safety issue. HIGHER MORTALITY IN BACTEREMIC PATIENTS: The excess mortality globally observed in cases of bacteremia (compared with patients without bacteremia) is markedly enhanced with regard to secondary bacteremia. Bacteremia is responsible for a significant increase in the overall duration of hospitalization. PROGNOSTIC FACTORS OF STAPHYLOCOCCI BACTEREMIA: The mortality rate is significantly higher in patients in whom initial therapy was inappropriate compared with those in whom it was adequate. The isolation of MRSA strains is a negative prognostic factor. PATIENTS AT RISK OF MRSA BACTEREMIA: Independent risk factors for MRSA bacteremia include prior exposure to antibiotics, a nosocomial origin, a history of hospitalization within the 6 preceding months, and the presence of a decubitus ulcer. To avoid MRSA bacteremias related to catheters, alternatives should be found to their use, all hygiene rules should be carefully respected, the insertion point should be carefully disinfected and protected, and the catheter should be removed as rapidly as possible.
- Published
- 2004
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.